“[Cost-effectiveness analysis of peginterferon beta-1a in Italian relapsing remitting multiple sclerosis management]”, FE, vol. 17, no. 2S, pp. 13–36, Jul. 2016, doi: 10.7175/fe.v17i2S.1230.